These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18217402)

  • 1. Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B.
    Lebensztejn DM; Skiba E; Werpachowska I; Sobaniec-Łotowska ME; Kaczmarski M
    Adv Med Sci; 2007; 52():120-4. PubMed ID: 18217402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.
    Mehta P; Ploutz-Snyder R; Nandi J; Rawlins SR; Sanderson SO; Levine RA
    Am J Gastroenterol; 2008 Apr; 103(4):928-36. PubMed ID: 18371145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.
    Lee CK; Perez-Atayde AR; Mitchell PD; Raza R; Afdhal NH; Jonas MM
    J Pediatr; 2013 Oct; 163(4):1058-64.e2. PubMed ID: 23759423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.
    Lebensztejn DM; Skiba E; Tobolczyk J; Sobaniec-Lotowska ME; Kaczmarski M
    World J Gastroenterol; 2005 Dec; 11(45):7192-6. PubMed ID: 16437671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.
    Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE
    Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.
    Saitou Y; Shiraki K; Yamanaka Y; Yamaguchi Y; Kawakita T; Yamamoto N; Sugimoto K; Murata K; Nakano T
    World J Gastroenterol; 2005 Jan; 11(4):476-81. PubMed ID: 15641129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
    Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
    Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.
    Pungpapong S; Nunes DP; Krishna M; Nakhleh R; Chambers K; Ghabril M; Dickson RC; Hughes CB; Steers J; Nguyen JH; Keaveny AP
    Liver Transpl; 2008 Sep; 14(9):1294-302. PubMed ID: 18756457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
    Esmat G; Metwally M; Zalata KR; Gadalla S; Abdel-Hamid M; Abouzied A; Shaheen AA; El-Raziky M; Khatab H; El-Kafrawy S; Mikhail N; Magder LS; Afdhal NH; Strickland GT
    J Hepatol; 2007 Apr; 46(4):620-7. PubMed ID: 17316875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
    Lebensztejn DM; Skiba E; Sobaniec-Łotowska ME; Kaczmarski M
    Adv Med Sci; 2007; 52():114-9. PubMed ID: 18217401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
    Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications.
    El-Asrar MA; Elbarbary NS; Ismail EA; Elshenity AM
    Blood Cells Mol Dis; 2016 Jan; 56(1):1-8. PubMed ID: 26603717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease.
    Tran A; Benzaken S; Saint-Paul MC; Guzman-Granier E; Hastier P; Pradier C; Barjoan EM; Demuth N; Longo F; Rampal P
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):989-93. PubMed ID: 11007134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
    Yan L; Deng Y; Zhou J; Zhao H; Wang G;
    Infection; 2018 Jun; 46(3):385-393. PubMed ID: 29600444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    Berres ML; Papen S; Pauels K; Schmitz P; Zaldivar MM; Hellerbrand C; Mueller T; Berg T; Weiskirchen R; Trautwein C; Wasmuth HE
    J Hepatol; 2009 Feb; 50(2):370-6. PubMed ID: 19070929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?
    Johansen JS; Møller S; Price PA; Bendtsen F; Junge J; Garbarsch C; Henriksen JH
    Scand J Gastroenterol; 1997 Jun; 32(6):582-90. PubMed ID: 9200292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
    Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
    Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis.
    Kamal SM; Turner B; He Q; Rasenack J; Bianchi L; Al Tawil A; Nooman A; Massoud M; Koziel MJ; Afdhal NH
    Hepatology; 2006 Apr; 43(4):771-9. PubMed ID: 16557547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.